Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 176,053 | 98,895 | 115,001 | 102,401 | 67,490 |
| Marketable Securities | 303,149 | 323,524 | 361,706 | 425,740 | 524,722 |
| Receivables | 5,930 | N/A | N/A | N/A | N/A |
| Inventories | 3,103 | N/A | N/A | N/A | N/A |
| TOTAL | $500,912 | $432,383 | $483,901 | $537,657 | $599,760 |
| Non-Current Assets | |||||
| PPE Net | 17,943 | 20,924 | 18,238 | 15,728 | 13,571 |
| Investments And Advances | 185,341 | 3,789 | 4,814 | 5,714 | 8,987 |
| Other Non-Current Assets | 21,592 | 10,558 | 10,376 | 10,098 | 7,924 |
| TOTAL | $224,876 | $35,271 | $33,428 | $31,540 | $30,482 |
| Total Assets | $725,788 | $467,654 | $517,329 | $569,197 | $630,242 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,396 | 5,546 | 3,454 | 6,990 | 8,010 |
| Accrued Expenses | 65,569 | 40,332 | 35,281 | 28,687 | 39,242 |
| TOTAL | $78,170 | $50,283 | $41,910 | $37,753 | $51,049 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,144 | 3,244 | 2,364 | 1,690 | 3,314 |
| Other Non-Current Liabilities | 5,996 | 6,170 | 6,796 | 6,664 | 4,768 |
| TOTAL | $21,399 | $22,472 | $23,978 | $24,520 | $21,001 |
| Total Liabilities | $99,569 | $72,755 | $65,888 | $62,273 | $72,050 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,787 | 62,579 | 62,570 | 62,523 | 62,499 |
| Common Shares | 7 | 6 | 6 | 6 | 6 |
| Retained earnings | -895,034 | -800,712 | -721,275 | -643,350 | -569,930 |
| Other shareholders' equity | 1,050 | -201 | 24 | -434 | -1,108 |
| TOTAL | $626,219 | $394,899 | $451,441 | $506,924 | $558,192 |
| Total Liabilities And Equity | $725,788 | $467,654 | $517,329 | $569,197 | $630,242 |